Association of CYP3A5*3 polymorphism with development of acute leukemia

Indian Journal of Human Genetics

Volumn 17, Issue 3, 2011, Pages 175-178

  Nageswara Rao, D ^a   Manjula, G ^a   Sailaja, K ^a   Surekha, D ^a   Raghunadharao, D ^a,b   Rajappa, Senthil ^a,b   Vishnupriya, S ^a  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute leukemia; CYP3A5; drug metabolism; polymorphism

Indexed keywords

CYTOCHROME P450 3A5; LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CARCINOGENESIS; DETOXIFICATION; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL;

EID: 84856367867     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.92098     Document Type: Article

References (9)

1. Friche E, Danks MK, Beck WT. Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo. Cancer Res 1992;52: 5701-6.
2. Ingelman-Sundberg M. Genetic susceptibility to adverse effects of drugs and environmental toxicants: The role of the CYP family of enzymes. Mutat Res 2001;482:11-9. (Pubitemid 32787077)
3. Felix CA, Walker AH, Lange BJ, Williams TM, Winicki NJ, Cheung NV, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci 1998;95:13176-81. (Pubitemid 28509544)
4. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility. Cancer Surv 1995;25:27-65.
5. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res 1991;19:5444.
6. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001;27:383-91. (Pubitemid 32268418)
7. Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, et al. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 2001;11:773-9. (Pubitemid 33151512)
8. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL, et al. Cell-cell interaction in prostate gene regulation and cyto-differentiation. Proc Natl Acad Sci USA 1997;94:10705-10. (Pubitemid 27430798)
9. Shen LJ, Chen FY, Wang T, Wang HR, Zhong JH, Han JY, et al. Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008;16:26-30.